The assay is designed to detect the N, S and RdRP genes. Credit: Andreas Lischka / Pixabay.

Health Canada has authorised Seegene’s Allplex SARS CoV-2 FluA/FluB/RSV Assay under its Interim Order.

The new multiplex real-time PCR assay is designed to identify the N, S and RdRP genes, which are used to detect SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV), in a single test.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

It enables the differentiation and amplification of respiratory symptoms simultaneously.

The Allplex SARS-CoV-2/Flu A/Flu B/RSV Assay can be run on the company’s integrated all-in-one automated platform, which enables high-throughput testing.

On 13 January, the company delivered 340,000 Covid-19 test kits to Canada to support the increasing demand for kits in the country.

Seegene chief sales and marketing officer Ho Yi said: “Demand for Covid-19 tests is skyrocketing due to the resurgence of confirmed cases.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

“We are fully prepared to supply enough test kits globally and will continue to be strong global partners in the effort to manage the spread of Covid-19.”

The company also stated that the latest approval will allow it to increase awareness of its product in countries close to Canada, such as those in Latin America.

In a separate development, Seegene has delivered more than five million Covid-19 test kits to Israel to support detection of the Omicron variant and reduce its spread.

Last December, the company delivered nearly 1.7 million Covid-19 test kits along with associated consumables. An additional 3.4 million tests are planned to be delivered this month.

Seegene will send various products to Israel, including its Allplex SARS CoV-2 FluA/FluB/RSV Assay and Allplex SARS-CoV-2 Master Assay.

Last month, the company confirmed that its Allplex SARS-CoV-2 Master Assay has the ability to detect the new Omicron Covid-19 variant.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact